Silent Neuroleptic Malignant Syndrome: A Case Report of Atypical Antipsychotic Induced Elevation of Creatinine Kinase and Altered Mental Status
34-year-old African American male with a diagnosis of schizophrenia was placed on aripiprazole and risperidone for psychosis and mood stabilization. Two days after medication initiation, the patient’s mentation was altered and he appeared confused with an elevated creatine kinase (CK) at 7101. Medications were held and CK normalized with IV fluids. Quetiapine was initiated after medical stabilization along with lithium and paliperidone palmitate injections. After the second dose of paliperidone palmitate, the patient’s mentation was altered, and repeat CK was 4272. The patient received 4 liters of IV fluid and his mental status returned to baseline.
There were two case studies noted that had marked increases in serum CK with risperidone use. The first was in an adolescent who was titrated to a dose of risperidone 3mg/ day but the only abnormality was an increase in his CK levels. The next case report was in a 40-year-old female who was on risperidone 2.5mg /day for one year. She had an intention tremor, minor muscle weakness of the lower extremities with a blood pressure of 140/100 and a pulse of 100. She manifested more clinical signs of possible Neuroleptic Malignant Syndrome (NMS). This case highlights the importance of laboratory investigations when there is a high suspicion of possible NMS. It also highlights that some cases of NMS may only present as altered mental status and increased CK in which quick treatment may lead to the prevention of full-blown clinical manifestations of NMS which could be life-threatening.
1. Kapur S, Zipursky R, Jones C, Remington G, Houle S.Relationship between dopamine D2 occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia. American Journal of Psychiatry. 2000;157(4):514-520. doi:10.1176/appi.ajp.157.4.514
2. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Medical Clinics of North America. 1993;77(1):185-202. doi:10.1016/s0025-7125(16)30278-4
3. Velamoor R. Neuroleptic malignant syndrome: A neuropsychiatric emergency: Recognition, prevention, and management. Asian Journal of Psychiatry. 2017;29:106-109. doi:10.1016/j.ajp.2017.05.004
4. Velamoor VR. Neuroleptic malignant syndrome. Drug Safety. 1998;19(1):73-82. doi:10.2165/00002018-199819010-00006
5. Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. American Journal of Psychiatry. 2007;164(6):870-876. doi:10.1176/ajp.2007.164.6.870
6. Levenson JL. Neuroleptic malignant syndrome. American Journal of Psychiatry. 1985;142(10):1137-1145. doi:10.1176/ajp.142.10.1137
7. Rosebush P, Stewart T. A prospective analysis of 24 episodes of neuroleptic malignant syndrome. American Journal of Psychiatry. 1989;146(6):717-725. doi:10.1176/ajp.146.6.717
8. Agarkar S. Elevated creatine kinase levels with second-generation antipsychotics. Journal of Neuropsychiatry and Clinical Neurosciences. 2011;23(3):E49-E50. doi:10.1176/jnp.23.3.jnpe49
9. Meltzer HY, Cola PA, Parsa M. Marked elevations of serum creatine kinase activity associated with antipsychotic drug treatment. Neuropsychopharmacology. 1996;15(4):395-405. doi:10.1016/0893-133x(95)00276-j
10. Nopoulos P, Flaum M, Miller DD. Atypical neuroleptic malignant syndrome (NMS) with an atypical neuroleptic: Clozapine-induced NMS without rigidity. Annals of Clinical Psychiatry. 1990;2(4):251-253. doi:10.3109/10401239009147953
11. Goates MG, Escobar JI. An apparent neuroleptic malignant syndrome without extrapyramidal symptoms upon initiation of clozapine therapy: Report of a case and results of a clozapine rechallenge. Journal of Clinical Psychopharmacology. 1992;12(2):139-140. doi:10.1097/00004714-199204000-00016
12. Holtmann M, Meyer AE, Pitzer M, Schmidt MH. Risperidone-induced Marked Elevation of Serum Creatine Kinase in Adolescence: A Case Report. Pharmacopsychiatry. 2003;36(6):317-318. doi:10.1055/s-2003-45121
13. Castelijns MH, Keeris LM, van der Hoeven JH. Risperidone-induced severe rhabdomyolysis: a case report. Clinical Case Reports and Reviews. 2016;2(6). doi:10.15761/ccrr.1000241